US 11377491
Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) monoclonal antibodies and method of use thereof to treat cancer
granted A61KA61K2039/505A61P
Quick answer
US patent 11377491 (Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) monoclonal antibodies and method of use thereof to treat cancer) held by The Board of Regents of the University of Texas System expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jul 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/00, A61P35/02